Microsoft-backed OpenAI Projects $5B Loss on $3.7B Sales This Year
Here Are the Medicare Part D Drugs Expected to Face 2025 Price Negotiations
Benzinga Bulls And Bears: Apple, Tesla, Novo Nordisk, Bitcoin — And Shiba Inu's Major Stablecoin Tease
Tim Cook-Led Apple Reportedly Abandons OpenAI Funding Round Discussions, But Nvidia And Microsoft Could Still Invest In ChatGPT-Parent
At the time of OpenAI's "disintegration", Apple has withdrawn from financing negotiations! Next year may require further fundraising.
Amidst rumors of high-level departures and plans to transition to a for-profit company causing a breakdown at OpenAI, Apple has exited the financing negotiations with OpenAI.
J&J, Legend Report Carvykti Cut Death Risk by 45% in Multiple Myeloma Study
J&J Releases Encouraging Data on Talvey Combination Therapies
Johnson & Johnson's CARVYKTI Is The First And Only Cell Therapy To Significantly Extend Overall Survival Versus Standard Therapies For Patients With Multiple Myeloma As Early As Second Line; 45% Reduction In Risk Of Death Achieved With CARVYKTI After...
Apple's Reviews Strategy, Cuts Film Budgets After Blockbuster Spend - What's Next for Apple TV+?
Amazon Prime Day Data Insights Before October Event: Apple Purchases Up 22%, Celsius Tops Grocery Category
Personal Income And Spending Disappoint, Super Micro Computer Lesson, BOJ Supporter As Japan PM
Market Clubhouse Morning Memo - September 27th, 2024 (Trade Strategy For SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META And TSLA)
Johnson & Johnson Announces Updated Results From The Investigational Phase 1b Trimm-2 Study Evaluating The Combination Of TALVEY And DARZALEX FASPRO Based Combination Shows Deep And Durable Responses In Patients With Relapsed Or Refractory Multiple...
iOS 18 Includes Apple's New Passwords App With End-to-End Encryption: Here's How You Use It
J&J Snaps Six Straight Sessions of Losses
$100 Invested In This Stock 5 Years Ago Would Be Worth $300 Today
Meta Analysts Highlight AI, VR Advances, See Growth Pushing It Toward Apple-Like Valuation
10 Information Technology Stocks With Whale Alerts In Today's Session
In-Depth Analysis: Johnson & Johnson Versus Competitors In Pharmaceuticals Industry
J&J to Shutter Cardiovascular, Metabolic Drug Unit: Report